Zobrazeno 1 - 10
of 81
pro vyhledávání: '"biotechnology companies"'
Autor:
Michael A. Cole, Guy R. Seabrook
Publikováno v:
Alzheimer’s & Dementia: Translational Research & Clinical Interventions, Vol 6, Iss 1, Pp n/a-n/a (2020)
Abstract Introduction The recent failure of several late‐stage Alzheimer's disease (AD) clinical trials focused on amyloid beta (Aβ) highlights the challenges of finding effective disease‐modifying therapeutics. Despite major advances in our und
Externí odkaz:
https://doaj.org/article/8bd5f1e121714801918256c835abb8fb
Publikováno v:
DIEM : Dubrovnik International Economic Meeting
Volume 6
Issue 1
Volume 6
Issue 1
In today's chaotic, complex, unpredictable, and extremely dynamic business environment, it is more than ever essential to operate in a way that will ensure sustainable operations and demand for companies’ goods or services. Employing contemporary c
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c4b4e87d4df71867618205a425c7441b
https://doi.org/10.17818/diem/2021/1.5
https://doi.org/10.17818/diem/2021/1.5
Publikováno v:
Garcia-Sancho, M, Lowe, J, Viry, G, Leng, R, Wong, M & Vermeulen, N 2022, ' Yeast sequencing : 'Network' genomics and institutional bridges ', Historical Studies in the Natural Sciences, vol. 52, no. 3, pp. 361-400 . https://doi.org/10.1525/hsns.2022.52.3.361
This paper examines the model of network genomics pioneered in the late 1980s and adopted in the European Commission-led Yeast Genome Sequencing Project (YGSP). It contrasted with the burgeoning large-scale center model being developed in the United
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3094::212170cd92ca0051c5f581c3da45186b
https://hdl.handle.net/20.500.11820/6e220d8f-e580-44df-ac73-90577a289d51
https://hdl.handle.net/20.500.11820/6e220d8f-e580-44df-ac73-90577a289d51
Publikováno v:
Modern Management Review, Vol XXI, Iss 4 (2016)
The objective of the paper is to present the possibilities of financing the development of companies in the pharmaceutical, biotechnological, and medical sectors through the capital market. The trading prices of selected companies on the Polish stock
Externí odkaz:
https://doaj.org/article/0f8d6c68a14e41898d951056a91547d8
Publikováno v:
Journal of Organizational Change Management, 2012, Vol. 25, Issue 5, pp. 699-708.
Externí odkaz:
http://www.emeraldinsight.com/doi/10.1108/09534811211254581
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Leonavičius, Jonas
The theme of overcoming market entry barriers has been the object of scientific researches for decades. Though the concept of market entry barriers and their classifications has been widely analysed, there is still lack of clarity of how to choose th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=od______3368::5d0282b66f2536eecaeebfb8fb6685d2
https://vb.ktu.edu/KTU:ELABAETD94659262&prefLang=en_US
https://vb.ktu.edu/KTU:ELABAETD94659262&prefLang=en_US
Autor:
Guy R. Seabrook, Michael A. Cole
Publikováno v:
Alzheimer’s & Dementia: Translational Research & Clinical Interventions, Vol 6, Iss 1, Pp n/a-n/a (2020)
Alzheimer's & Dementia : Translational Research & Clinical Interventions
Alzheimer's & Dementia : Translational Research & Clinical Interventions
Introduction The recent failure of several late‐stage Alzheimer's disease (AD) clinical trials focused on amyloid beta (Aβ) highlights the challenges of finding effective disease‐modifying therapeutics. Despite major advances in our understandin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c0636de02139604121c243d30501d6a4
https://doaj.org/article/8bd5f1e121714801918256c835abb8fb
https://doaj.org/article/8bd5f1e121714801918256c835abb8fb